Research Article
Evaluation and Surgical Treatment Strategies for Solitary Pulmonary Nodules
Yang Q, Xiao J, Wu L*, Zhao X, Sun G, Chang P, Zhao J and Wang Z
Department of Cardiothoracic Surgery, Second Military Medical University, China
*Corresponding author: Lihui Wu, Department of Cardiothoracic Surgery, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China
Published: 20 Jul, 2016
Cite this article as: Yang Q, Xiao J, Wu L, Zhao X, Sun G,
Chang P, et al. Evaluation and Surgical
Treatment Strategies for Solitary
Pulmonary Nodules. Clin Oncol. 2016;
1: 1032.
Abstract
Background: The origin of solitary pulmonary nodules (SPN) is difficult to determine because they
do not exhibit distinct imaging features; further, it is not easy to determine if the lesions are benign
or malignant, which may lead to misdiagnosis and delayed treatment. Caution should be taken
during intraoperative diagnosis and surgical treatment of SPN to avoid the use of invasive diagnosis
methods and excessive treatment. In this study, we investigated the diagnosis and treatment
strategies for patients with SPNs.
Methods: The clinical data of 167 patients who underwent surgical removal of SPNs between
January 2010 and December 2015 was collected for retrospective analysis.
Results: Tumor removal was achieved by conventional incision or video-assisted small-incision
surgery. Malignant lesions were confirmed in 69 patients (41.32%) by performing pathological
examination after operation. Different degrees of hilus pulmonis and mediastinum lymph node
metastases were observed in 11 patients. The preoperative diagnostic accordance rates and diagnostic
specificity of chest computed tomography (CT), CT-guided percutaneous aspiration biopsy, and
positron emission tomography (PET)/CT examinations were significant difference. The diagnostic
accordance rates were 70.77%, 85.96%, and 91.67%, respectively (P=0.002), diagnostic sensitivities
were 86.06%, 77.78%, 95.83%, respectively (P=0.165), diagnostic specificities were 68.18%, 100%,
87.50%, respectively (P=0.003).
Conclusion: Preoperative chest CT, CT-guided percutaneous lung biopsy, and PET/CT
examinations could be used for the diagnosis of SPNs. Surgical resection has both diagnostic and
therapeutic implications for SPNs. Surgical treatment should be personalized according to the
patient’s condition. Excessive or conservative surgery must be avoided as far as possible to avoid
pathological misdiagnosis.
Keywords: Solitary pulmonary nodule; Diagnosis; Pulmonary resection
Introduction
The origin of solitary pulmonary nodules (SPNs) is not known; on chest X-ray (CXR) scans,
SPNs appear as a well-defined opaque lesion of 3cm or less in diameter surrounded by normal lung
without any associated atelectasis or adenopathy [1]. Developments in radiology have enabled the
detection of SPNs that are important indicators of early-stage lung cancers; this aspect has attracted
the attention of scientists and is under investigation [2]. In mass screening studies, SPNs were
identified in 0.09%-0.2% CXR examinations. This percentage has increased with the increasing use
of chest computed tomography (CT) techniques. In the past 20 years, the introduction of modern
imaging techniques, fine-needle aspiration (FNA) [3], and positron emission tomography (PET)
[4] has improved the scope of diagnostic modalities; however, no technique can provide a definitive
diagnosis of SPNs [5].
Due to the complex nature of SPNs and the clinical difficulties associated with the definitive
diagnosis of benign and malignant lesions, the treatment of these tumors is often delayed.
Qualitative diagnosis and surgical strategies for the treatment of SPNs have been the challenges
for contemporary lung surgery. Accurate determination of the nature of SPN plays a crucial role
in guiding the treatment of the disease. In clinical practice, malignant lesions should be resected as
early as possible to avoid the spread of the disease, and unnecessary thoracotomy should be avoided
for benign lesions. Therefore, it is crucial for both radiologists and lung surgeons to determine if an
SPN is benign or malignant [6]. However, surgery is the only option if definitive diagnosis cannot
be established [7].In this study, we report our experience with minimal invasive
surgery for the treatment of SPNs and our analysis of the evolution of
diagnostic-therapeutic techniques developed in the recent 10 years.
Table 1
Table 1
Chest CT, CT-guided transthoracic needle biopsy, PET/CT examinations before operation and the diagnostic accordance rates.
Table 2
Methods
Between January 2010 and December 2015, 167 patients
underwent surgical removal of SPNs at the Department of
Cardiothoracic Surgery, Changzheng Hospital, and Second Military
Medical University. We performed a retrospective analysis of the
data of these patients. Our study was approved by The Institutional
Review Board of Changzheng Hospital, Second Military Medical
University, Shanghai, China. Among the 167 patients, 116 (69.46%)
were males and 51 (30.54%) were females, and their age was in the
range of 30-79 years (average, 52.4 years). Eighty-eight (52.69%)
non-symptomatic patients were incidentally diagnosed during
physical fitness examinations; 45 (26.95%) were diagnosed when
they presented at a hospital with different degrees of respiratory
symptoms such as cough, bloody sputum, and chest pain; and 34
(20.36%) were diagnosed during CXR examination or CT scanning
for detection of other diseases, among which 7 (4.19%) patients had
a history of malignant tumors. All patients underwent preoperative
CXR examination and 64-slice spiral CT (SCT) enhanced scanning
(GE Discovery CT 750 HD 64-slice, detector collimation 64×0.6mm,
pitch 0.9, rotation time 0.4 sec, scan time ~5sec. reconstruction slice
thickness 2.5mm, interval 2.5mm, Window Wide 400 Hu, Window
Level 40Hu).
After completing preoperative examinations, all 167 patients
underwent endotracheal intubation with a double-lumen catheter
and were operated under balanced general anesthesia. For patients
in whom malignant tumors were confirmed preoperatively, standard
lobectomy plus lymph node dissection was performed by making a
conventional incision or by a video-assisted small thoracic incision.
For patients in whom peripheral nodules could not be confirmed
preoperatively, wedge excision of tumor-containing lung tissues
was performed by making a small incision or by using a videoassisted
thoracoscope to ensure adequate resection and no residual
tumor. Finally, frozen tumors sections were sent for pathological
examination. The specimens of nodules located near the hilus
pulmonis were obtained while ensuring safety during surgery. If it
was indeed difficult to obtain a specimen of a lesion or if preoperative
examination suggested that the lesion was highly malignant, a lung
lobe or lung segment was resected to determine whether to perform an
extended resection and lymph node dissection. For patients who were
diagnosed with malignant lesions by rapid pathological examination
and whose pulmonary function can tolerate, standard lung resection
plus lymph node dissection were performed; further, for patients
whose pulmonary function cannot tolerate, wedge resection of the
lung segment or the lung was performed. For patients with benign
lesions, the lung edge was sutured to complete the surgical procedure.
If active proliferation was not suggested or confirmed by rapid
pathological examination, the scope of resection was extended up to
the extent to which pulmonary function allowed lobectomy. After
surgery, the patients received combined therapy for lung cancer and
preventive treatment for tuberculosis and fungal infection.
Statistical analysis
Descriptive statistics and crosstabs were used to determine the
correlation between benign or malignant SPNs and respiratory
symptoms. Kruskal-Wallis one-way Analysis of Variance (ANOVA)
was used to determine the correlation between the size of SPN and
their benign or malignant nature. The nonparametric Chi-square
test was applied to determine the diagnostic accordance rate of
preoperative chest CT, CT-guided percutaneous lung biopsy, and
PET/CT examinations. A value of P< 0.05 was considered statistically
significant. Statistical analysis and data processing were performed
using SPSS 12.0 software.
Results
The CT images of lung nodules obtained using the standard lung
window revealed that the nodules were ≤3 cm in diameter; the nodules
of 96 (57.49%) patients showed the signs of malignancy and those of
remaining 71 (42.51%) patients showed benign features. Peripheral
pulmonary nodules were observed in all patients. Preoperative CTguided
percutaneous lung biopsy examination was performed in 57
(34.13%) patients and PET or PET/CT scanning were performed for
48 (28.74%) patients. According to economic conditions for patients
and diagnostic uncertainty for doctors, 28 (29.17%) cases of 96 patients
CT images showed the signs of malignancy and 20 (28.17%) cases of
71 patients showed benign features were underwent PET or PET/CT
scanning. The standard uptake value (SUV) ≥2.5 was considered as
the diagnostic standard of malignant pulmonary nodules.
Out of the 167 patients, 104 (62.28%) underwent wedge
resection, 36 (21.56%) underwent upper lobe resection, 19 (11.38%)
underwent lower lobe resection, and 8 (4.79%) underwent middle
lobe resection. Rapid examination of the frozen biopsy specimens
was performed intraoperatively. Benign lesions were confirmed in 98
patients (58.68%); pneumonic nodules were detected in 30 (17.96%)
patients, inflammatory pseudotumors in 19 (11.38%) patients,
pulmonary hamartoma in 17 (10.18%) patients, tuberculosis in 13
(7.78%) patients, fibrous nodules in 9 (5.39%) patients, sclerosing
hemangioma in 5 (2.99%) patients, and cryptococcal granuloma
in 5 (2.99%) patients. Malignant lesions were confirmed in 69
patients (41.32%); adenocarcinoma was detected in 35 (20.96%)
patients, squamous cell carcinoma in 18 (10.78%) patients, and
adenosquamous carcinoma in 5 (2.99%) patients, small cell carcinoma
in 4 (2.40%) patients, lung metastasis from breast cancer in 4 (2.40%)
patients, and lung metastasis from rectal cancer in 3 (1.80%) patients.
Out of the 88 patients in whom SPNs were detected during physical
fitness examination, 32 (36.36%) patients had malignant tumors;
of the 45 patients with respiratory symptoms, 27 (60.0%) patients
had malignant tumors; and out of the 34 patients who underwent
CXR or CT examinations for other diseases, 10 (29.41%) patients
had malignant tumors. The diagnosis rate of malignant SPN was
significantly higher in the group with respiratory symptoms than
in the groups who had undergone physical fitness examination (P =
0.009) or CXR and CT examination for other diseases (P = 0.007).
Postoperatively, non-small cell lung lesions (58 patients) were
staged on the basis of the 2009 International Staging System for lung
cancer; 34 (58.62%) patients were stage Ia (T1N0M0), 13 (22.41%)
were stage Ib (T2aN0M0), 5 (8.62%) were stage IIa (T1N1M0 and
T2aN1M0), and 3 (5.17%) each were stage IIb (T3N0M0) and
stage IIIa (T1N2M0 and T2aN2M0). The number of patients who
underwent preoperative chest CT, CT-guided percutaneous lung
biopsy, and PET/CT examinations, and their diagnostic accordance
rates diagnostic sensitivity and specificity are listed in Table 1. There
were significant difference in the diagnostic accordance rates and
diagnostic specificity among the 3 detection methods. The accuracy
of PET/CT examination was higher than that of chest CT and CTguided
percutaneous needle aspiration biopsy examination of the
lung. Diagnostic specificity of CT-guided Transthoracic Needle
Biopsy (TNB) was higher than PET/CT and CT. But there was no
significant difference in the diagnostic sensitivity. The nature of SPNs,
whether benign or malignant, with different diameters as determined
by postoperative pathological examination is shown in Table 2.
Statistical analysis of the grouped information of the 3 groups using
Kruskal-Wallis one-way ANOVA test indicated that the size of the
SPNs in our study group was not related to the benign or malignant
nature of the nodules (P = 0.769; P > 0.05). Out of the 69 patients
with malignant lesions, 11 (15.94%) had hilar or mediastinal lymph
node metastases. Sixty-four patients were followed up 1~72 months
postoperatively (average, 39.8 months), and the follow-up rate was
92.75%, 3 (4.69%) patients died during follow period, 2 (3.13%)
patients received.
Discussion
SPNs are mostly located in the peripheral lung; however, imaging
examination of peripheral lungs reveals clinically asymptomatic
pulmonary nodules with no typical characteristics [2]. Due to the
rapid development of CT and PET/CT techniques and people’s
awareness of community physical fitness examinations, the diagnosis
rate of SPNs and the opportunities for early detection of lung cancer
have increased significantly. Reported data and increasing incidences
of lung cancer indicate that malignant tumors account for about
60%-70% of SPNs and benign lesions account for only 30%–40%
of SPNs [6,7]. Out of the 167 examined patients, malignant lesions
were detected in about 41.32% patients. But there were limitations;
the findings of this paper could not be applied to all SPNs. Since
there are patients with a solitary nodule which has benign features
and demonstrates no growth over time, which would not be referred
for surgery but followed by the treating physician [8-10]. The size
of pulmonary nodules in these patients was not associated with the
benign or malignant nature of the lesion. Out of the 167 patients with
SPN, primary lung cancer ranked the first in single disease, followed
by pneumonic nodules, inflammatory pseudotumors, pulmonary
hamartomas, fibrous nodules, tuberculosis, sclerosing hemangiomas,
cryptococcal granulomas, and lung metastases. Adenocarcinoma was
the most predominant form of primary lung cancer, possibly because
adenocarcinoma mainly affected the peripheral lung [11].
Radiological diagnosis of the SPN
The complex origin of SPNs and their unremarkable imaging
features complicate the diagnosis of benign and malignant SPNs,
which often leads to misdiagnosis and delayed treatment. Caution
should be taken during intraoperative diagnosis and treatment of
SPNs to avoid using unnecessary methods of invasive diagnosis and
excessive treatment. Majority of SPN patients are asymptomatic and
are diagnosed during physical fitness examinations. CXR examination
is generally used for the diagnosis of chest disease, and this method
is commonly used for general survey and screening purposes. The
use of CT, particularly, SCT and high-resolution CT (HRCT), should
be advocated for the detection and diagnosis of SPN. According to
the CT characteristics of lesions, correct diagnosis can be made for
most nodules, with a reported diagnostic rate of 86.0% [12]. In our
study group, all patients underwent enhanced SCT examination, with
diagnostic accordance rate of 70.77%, thereby indicating that this
technique has a very good diagnostic value. PET detects tumors based
on the metabolism of tumor cells, i.e., it evaluates the physiological
rather than anatomical characteristics and is therefore considered
to have higher accordance rate, sensitivity and specificity than CT.
One limitation of PET is that it fails to identify false positive and false
negative cases. Because fludeoxyglucose (FDG) is not a tumor-specific
imaging agent, tuberculosis, proliferative granuloma, inflammation,
sarcoidosis, and other benign nodules may lead to false-positive PET
findings. In our study group, 3 patients for whom pneumonic nodular
and tuberculosis were confirmed in pathological examination showed
false-positive findings on PET. PET diagnosis yielded relatively low
false negative results, with cell types and differentiation degree of
lung cancers being the key factors of false negative findings. The
integration of functional imaging and anatomical structures is
achieved in PET/CT. For pulmonary nodules that are difficult to
identify by CT, non-invasive examination by PET/CT should be
preferred. However, since PET/CT is costly, its widespread clinical
application is limited [13], and for solitary pure ground-glass nodules
>5mm, PET/CT is of limited value, potentially misleading, and PET/
CT is considered for solitary part-solid nodules >10mm [7]. CTguided
percutaneous aspiration biopsy examination of lung nodules
is a common preoperative detection method used in recent years; this
method is reported to detect malignancy with a sensitivity of 60%-
90%. However, because of the small size of the majority of pulmonary
nodules and differences in the imaging and paracentesis techniques,
the diagnostic rate of this CT-guided technique varies greatly. This
technique was performed in 57 patients, and the diagnostic accordance
rate was 85.96%, and the diagnostic specificity was 100%. Since this
is an invasive examination method, it may result in pneumothorax,
hemothorax, and other complications after the operation and is
not cost efficient. Therefore, CT-guided percutaneous aspiration
biopsy of lung nodules is also subject to certain limitations. Patients
with negative aspiration biopsy results and high risk of lung cancer
suspected by CT should immediately undergo surgical treatment
[14]. Patients with no diagnostic evidence of SPN or lung cancer in
CT or not willing to undergo aspiration biopsy should be periodically
followed up for a short term. The size of majority of peripheral lung
lesions may change within 1-3 months. During the follow up period,
anti-inflammatory or anti-tuberculosis treatment may be given, but if
no improvement is observed or the lesions increase in size, surgical
treatment should be proactively performed [15]. Sixteen patients
underwent surgery and were followed up for 20–60 days, which was
invalid, and 8 were confirmed as lung cancers.
Surgical treatment and pathological examination of SPN
SPNs can be confirmed intraoperatively and also treated thereafter.
The degree of surgical trauma can be reduced by introducing a small
incision or performing video-assisted thoracoscopic surgery for
tumor resection; the nature of the tumor can be confirmed before
deciding the type of surgery by performing pathological examination
of the intraoperatively obtained frozen sections [16]. We advocate
the pathological examination of frozen tumor sections obtained
after surgical resection of SPN, regardless of whether preoperative
pathological examination has been performed, especially when
preoperative pathological examination suggests benign lesions.
Excessive or conservative surgery due to pathological misdiagnosis
should be avoided as far as possible.
The results of postoperative pathological staging suggest that
not all types of lung cancers with SPN are early-stage lung cancers.
Pathological examination revealed 11 cases (18.97%) with different
degrees of hilar and mediastinal lymph node metastases. In addition,
past history of malignant nodules also indicates the possibility that
the nodules were malignant tumors. In our study group, there were
7 patients with history of breast cancer and rectal cancer, which
were confirmed to be metastasised by postoperative pathological
examination. The 5-year survival rate of the patients after early surgical
resection of SPN lung cancer was up to 80% or high, while the 5-year
survival rate of advanced lung cancer that could be operated was only
30%–40%; these findings suggest the significance of early diagnosis
and treatment of SPN lung cancer. Complete surgical excision of
the lesions will help relieve the patient’s psychological pressure and
prevent malignant transformation [17]. Video-assisted thoracoscopy
is currently developing rapidly; this technique has the advantages of
being minimal invasive, fully revealed vision, clear images, and few
postoperative complications, and it appears to be gradually accepted
by several patients. However, thoracoscopy has certain limitations
because it is expensive, technically demanding, and has less scope.
Sixty-three patients with SPN underwent surgery at our hospital
via a small axillary incision and some patients underwent routine
lobectomy incision through extended incisions; all patients showed
good postoperative recovery and no patient developed serious
perioperative complications. Therefore, presently, this is a good
treatment method that can be adopted by primary hospitals at the
present stage.
References
- Good CA, Wilson TW. The solitary circumscribed pulmonary nodule: study of seven hundred and five cases encountered roentgenologically in a period of three and one half years. J Am Med Assoc. 1958; 166: 210-215.
- Cronin P, Dwamena BA, Kelly AM, Bernstein SJ, Carlos RC. Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests. Eur Radiol. 2008; 18: 1840-1856.
- Yankelevitz DF, Henschke CI, Koizumi JH, Altorki NK, Libby D. CTguided transthoracic needle biopsy of small solitary pulmonary nodules. Clin Imaging. 1997; 21: 107-110.
- sindoni A, Minutoli F, Pontoriero A, Iatì G, Baldari S, Pergolizzi S, et al. Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature. Lung Cancer. 2016; 96: 78-86.
- Cha MJ, Lee KS, Kim HS, Lee SW, Jeong CJ, Kim EY, et al. Improvement in imaging diagnosis technique and modalities for solitary pulmonary nodules: from ground-glass opacity nodules to part-solid and solid nodules. Expert Rev Respir Med. 2016; 10: 216-278.
- Baldwin DR. Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation. Chest. 2015; 148: 1365-1367.
- Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013; 266: 304-317.
- Yonemori K, Tateishi U, Uno H, Yonemori Y, Tsuta K, Takeuchi M, et al. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology. 2007; 12: 856-862.
- Davies B, Ghosh S, Hopkinson D, Vaughan R, Rocco G. Solitary pulmonary nodules: pathological outcome of 150 consecutively resected lesions. Interact Cardiovasc Thorac Surg. 2005; 4: 18-20.
- MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guideline for management of small Pulmonary Nodules detected on CT scans: A statement from the Fleischner Society. Radiology. 2005; 237: 395-400.
- Kadara H, Kabbout M, Wistuba II. Pulmonary adenocarcinoma: A renewed entity in 2011. Respirology. 2012; 17: 50-65.
- Cronin P, Dwamena BA, Kelly AM, Bernstein SJ, Carlos RC. Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests. Eur Radiol. 2008; 18: 1840-1856.
- Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg. 2006; 82: 1016-1020.
- D'Alessandro V, Parracino T, Stranieri A, Greco A, De Cata A, Sperandeo M, et al. Computed-tomographic-guided biopsy of thoracic nodules: a revision of 583 lesions. Clin Ter. 2007; 158: 509-513.
- Tanner NT, Aggarwal J, Gould MK, Kearney P, Diette G, Vachani A, et al. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015; 148: 1405-1414.
- Sienko A, Allen TC, Zander DS, Cagle PT. Frozen section of lung specimens. Arch Pathol Lab Med. 2005; 129: 1602-1609.
- Harzheim D, Eberhardt R, Hoffmann H, Herth FJ. The Solitary Pulmonary Nodule. Respiration. 2015; 90: 160-172.